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Developmentof a Methodfor theSerologicalDifferentiationBetweenAnimalsEither
VaccinatedwithKilledVirusVaccineorInfectedbyBovineViralDiarrheaVirus(BVDV)
Jimmy Kwangand E. Travis Llttledlke1
Introduction
Bovineviraldiarrhea(BVO),causedby the BVO virus,
hasbeenrecognizedinmanypartsof theworldandis con-
sideredto have a markedeconomicimpacton the cattle
industry. In the U.S. alone,serological surveysindicated
that60 to 80% of the cattlepopulationhaveantibodiesto
the virus. Thereare manystrainsof bovineviraldiarrhea
virus(BVOV)whichdifferintheirabilityto causechangesin
cellculture.Thus,cytopathicandnoncytopathicbiotypesof
BVOVareidentified.Thecytopathicstrainsinducea vacuo-
lationof the infectedculturedcells, where noncytopathic
strainsdo not.
Controlof BVOV hasbeenattemptedfor manyyearsby
use of either modified-liveor killedvirus vaccines. The
killedvirusvaccineis more commonlyused. The modified-
livevirusvaccineis knownto cause complicationsduring
pregnancy,potentiallyfetopathogeniceffectsbeinga major
concern. Thereis evidencethatvaccinationof persistently
infectedcattlewithmodified-livevirusvaccinecan resultin
severemucosaldisease. Oueto the ubiquitousnatureof
BVOV, producersmayfind advantagesin designingBVO
controlproceduresfor a herd to be able to differentiate
betweencattlethat 1) have receivedmodified-liveBVO
virusvaccination,2)havereceivedkilledBVOvirusvaccina-
tion,or 3) werenaturallyinfected.This studyexploredthe
potentialof BVOVprotein,p80,to allowdifferentiationofthe
abovethreeconditions.
The genomeof an isolateof a BVOV strainhas been
sequenced. Encodedwithinthe genomeare at leastfour
primarygene products(proteins):p20,gp116,p125,and
p133. There is evidencethatp125polypeptideprecursor
givesrise to p80 polypeptidedueto the breakdownof this
precursorproteinincellsinfectedwithBVOV. The p80area
of the BVOV genomeis well conservedin themanyBVOV
strainsthathavebeenisolated.
Procedure
New molecular biology techniques permittedthe manipu-
lation of the BVOV genome to allow isolation and recombi-
nation of the p80 gene into a ONA structure designed for
productionof the p80 specific protein. The recombinantp80
protein was produced, expressed, and purified in sufficient
quantities to develop a specific immuno-blot assay for
BVOV antibodies in cattle sera. Twenty-four cattle sera
were tested: eight of the cattle were vaccinated with modi-
fied-live virus vaccine, eight were vaccinated with killed
virus vaccine, and eightwere naturally infectedwith BVO.
Results
The immuno-blotassay thatwas developed was testedfor
BVOV-p80 antigen-antibodyreaction. When the BVOV-p80
protein was reacted with the cattle sera in the immuno-blot
test, the following results were obtained: all sera from modi-
fied-live virus vaccinated cattle were positive; all sera from
killedvirus vaccinatedcattle were negative,and all sera from
naturallyinfectedcattlewere positive (Table 1). Since p80 is
not a structural protein of the virus and the killed virus
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doesn't replicate in the host cell, there is not sufficient paO
antigen in cattle vaccinatedwith killed BVO vaccine to cause
productionof p80 antibodies in cattle. Therefore, cattle vac-
cinated with the killed BVO vaccine either do not make anti-
bodies or do not produce detectable levels of antibodies to
the p80 region of the virus. Thus, the cattle test negative.
However, modified-livevirus used for vaccination replicated
in the host cell aftervaccinationand produced large amounts
of p80; therefore, antibodies were produced in the cattle to
the paOand the cattletestedpositive.
The significance of this finding is two-fold. First, p80 is
capable of differentiating between the modified-live and
killed virus vaccines. Second, if a herd was vaccinated only
with killedvirus vaccine and tested with p80 immuno assay,
the expected results would be negative-if the herd was
clean of BVOV. Any positive results would indicate that a
source of natural infectionmust be present in the herd. This
source could be from persistentlyviremic BVO carriers, that
mayor may not exhibit signs of the infection, but would
spread BVO throughout the herd and give birth to carrier
calves which would continue the spread of BVO in the herd.
To ultimatelycontrol BVOV, carriers of the BVO virus must
be identifiedand eliminated from the herd and no new car-
rier cattle added. In addition, effective vaccination of the
cattle before breeding would protect the fetal calves from
becoming carriers and perpetuatingBVO in the herd.
Table1-Comparlsonof BVDVp80antibodyresponseIn
cattlevaccinatedwitheitherMLVV,KVV,or NI with
virus
Animalno.
BVDV
exposure
Serum paD
neutralizationtest immune-blotassay
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
MLVV
32 +
16 +
64 +
16 +
32 +
32 +
32 +
32 +
4
8
4
<2
<2
<2
4
8
>256 +
>256 +
>256 +
>256 +
128 +
>256 +
>256 +
128 +
KVV
NI
BVDV-Bovine viral diarrhea virus.
MLW _ Modified.live virus vaccine.
KVV - Killed virus vaccine.
NI _ Naturally infected.
